Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor
Xiufang Zheng(Roche (China)), Hongying Yun(Roche (China)), Kunlun Xiang(Shanghai Medical College of Fudan University), Song Feng(Roche (China)), Xin Yu(Roche (China)), Hong C. Shen(Roche (China)), Mingwei Zhou(Roche (China)), Baoxia Wang(Roche (China)), Bo Zhang(Roche (China)), Li Chen(Roche (China)), Lisha Wang(Fudan University Shanghai Cancer Center), Tao Guo(WuXi AppTec (China)), Chungen Liang(Roche (China)), Yongfu Liu(Roche (China)), Lu Gao(Second Military Medical University), Jim Zhen Wu, Gang Zou
Cited by 96
Related Papers
Recent advances in syntheses of heterocycles and carbocycles via homogeneous gold catalysis. Part 1: Heteroatom addition and hydroarylation reactions of alkynes, allenes, and alkenes
|Tetrahedron|2008|521
Recent advances in syntheses of carbocycles and heterocycles via homogeneous gold catalysis. Part 2: Cyclizations and cycloadditions
|Tetrahedron|2008|322
Ruthenium-Catalyzed Intramolecular [5 + 2] Cycloadditions
|Journal of the American Chemical Society|2000|237
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
|Journal of Medicinal Chemistry|2011|230